Birchview Capital, LP - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 39 filers reported holding ANGION BIOMEDICA CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q1 2023$32
-27.3%
54,3920.0%0.02%
-19.4%
Q4 2022$44
-99.9%
54,3920.0%0.03%
-11.4%
Q3 2022$50,000
-19.4%
54,3920.0%0.04%
-22.2%
Q2 2022$62,000
-46.1%
54,3920.0%0.04%
-45.8%
Q1 2022$115,000
-27.2%
54,3920.0%0.08%
-18.6%
Q4 2021$158,000
-70.2%
54,3920.0%0.10%
-71.7%
Q3 2021$531,000
-72.6%
54,392
-10.3%
0.36%
-68.9%
Q2 2021$1,938,000
+77.0%
60,6150.0%1.16%
+78.3%
Q1 2021$1,095,00060,6150.65%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q3 2022
NameSharesValueWeighting ↓
CM Management, LLC 600,000$552,0000.62%
Nantahala Capital Management 1,066,012$981,0000.06%
BVF INC/IL 1,071,297$986,0000.04%
Birchview Capital, LP 54,392$50,0000.04%
Park West Asset Management LLC 370,724$341,0000.02%
Cannell Capital 40,181$37,0000.01%
Patriot Financial Group Insurance Agency, LLC 36,500$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,000$161,0000.00%
Valeo Financial Advisors, LLC 63,659$59,0000.00%
Ergoteles LLC 78,857$73,0000.00%
View complete list of ANGION BIOMEDICA CORP shareholders